theflyonthewall.com: the Fastest Breaking Financial and Equity News on the Web

News Breaks

09:15 EDT

VNDA

theflyonthewall.com:		Vanda Pharmaceuticals risk/reward favorable at current levels, says Caris
		Caris finds the risk/reward on Vanda shares favorable with the company's launch of Fanapt approaching. The firm reiterates a Buy rating on the stock with a $20 price target. :theflyonthewall.com

News For VNDA From The Last 14 Days

Check below for free stories on VNDA the last two weeks.

There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.

February 2, 2010

09:26 EDT

VNDA

theflyonthewall.com:		Vanda Pharmaceuticals initiated with a Buy at Madison Williams
		Target $19. :theflyonthewall.com